Pulmonology and respiratory Archives - Page 2 of 3

Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain

Authors: F J González-Barcala, X Muñoz-Gall, E Mariscal, A García, S Yang, G van de Wetering, J L Izquierdo-Alonso Published: Journal of Medical Economics, 2021 View publication Aim To analyse the cost-effectiveness...

Relationship between the Asthma Control Test (ACT) and other outcomes: A targeted literature review

Authors: B C P van Dijk, H Svedsater, A Heddini, L Nelsen, J S Balradj, C Alleman Published: BMC Pulmonary Medicine, 2020 View publication Background The Asthma Control Test (ACT) has been...

Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome

Authors: S H Abman, N R Fox, M I Malik, S S Kelkar, S L Corman, S Rege, J Bhaloo, R Shah, R-J Shei, D Saporito, N Shamseddine, E DeBoer, G J...

Real-world outcomes of ivacaftor treatment in people with cystic fibrosis: a systematic review

Authors: J Duckers, B Lesher, T Thorat, E Lucas, L J McGarry, K Chandarana, F De Iorio Published: Journal of Clinical Medicine, 2021 View publication Abstract Cystic fibrosis (CF) is a rare,...

Psychometric validation of the EQ-5D-3L in patients with Nontuberculous Mycobacterial (NTM) lung disease caused by Mycobacterium avium Complex (MAC)

Authors: A Shah, X Ng, R Shah, C Solem, P Wang, M Obradovic Published: Patient related outcome measures, 2021 View publication Purpose This analysis evaluated the psychometric properties of the EQ-5D-3L among...

The Cystic Fibrosis Impact Questionnaire: qualitative development and cognitive evaluation of a new patient-reported outcome instrument to assess the life impacts of cystic fibrosis

Authors: K P McCarrier, M Hassan, P Hodgkins, E Suthoff, L J McGarry, M L Martin Published: Journal of patient-reported outcomes, 2020 View publication Background Patients with cystic fibrosis (CF) experience significant...

Healthcare utilization and costs among chronic bronchitis patients treated with maintenance medications from a US managed care population

Authors: A Abudagga, S X Sun, H Tan, C T Solem Published: Journal of Medical Economics, 2013 View publication Objectives This study aimed to examine the real-world healthcare resource utilization (HCRU) and...

Nontuberculous mycobacterial lung disease caused by mycobacterium avium complex – disease burden, unmet needs, and advances in treatment developments

Authors: J Van Ingen, M Obradovic, M Hassan, B Lesher, E Hart, A Chatterjee, C Daley Published: Expert Review of Respiratory Medicine, 2021 View publication Introduction Nontuberculous mycobacterial (NTM) lung disease (LD)...

Nurses’ role in improving outcomes for patients with severe asthma

Authors: Leanne J Holmes Published: Nursing Times, 2017 View publication Abstract Severe asthma has major adverse effects on patients’ quality of life, the use of healthcare resources and society as a whole....

News